Biohit Oyj : Publication of Biohit Oyj Annual Report 2025

About this update from Biohit Oyj Class B

English Finnish Published: 2026-03-18 08:30:00 CET Biohit Oyj - Annual Financial Report Publication of Biohit Oyj Annual Report 2025 Biohit Oyj Annual Financial Report March 18, 2026 at 09:30 am local time (EET) Biohit Oyj's Annual Report 2025 is published today in PDF and XHTML format. The annual report contains financial statements for 2025, the Report of the Board of Directors and Corporate Governance Statements. Annual report is published in Finnish and English, and it can be read and downloaded from Biohit company website: Biohit (biohithealthcare.com) CEO Jussi Hahtela, Biohit Oyj tel. +358 9 773 https://www.biohithealthcare.com ">[email protected] https://www.biohithealthcare.com Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com 74370089ATTSNBXJVT29-2025-12-31-1-en.zip https://attachment.news.eu.nasdaq.com/aa27c74003accd062269b5b14a2dda388 Biohit Oyj Annual Report 2025.pdf https://attachment.news.eu.nasdaq.com/a79bc49d49b8698a50748dd64c2397fc8 Company News Subscribe European Market Activity Nasdaq Europe © 2025, Nasdaq, Inc. All Rights Reserved.

View stock analysis, news, and events for Biohit Oyj Class B